Angiogenesis
Apoptosis
Autophagy
Cell Cycle
Cytoskeletal Signaling
DNA Damage
Endocrinology&Hormones
Epigenetics
ER stress & UPR
GPCR & G Protein
Immunology&Inflammation
JAK/STAT
MAPK
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Metabolism
Microbiology
Natural products
Neuronal Signaling
NF-κB
PI3K/Akt/mTOR
Proteases
Protein Tyrosine Kinase
Stem Cells & Wnt
TGF-beta/Smad
Transmembrane Transporters
Ubiquitin
Others
Screening library
Peptide
Enzymes and proteins
Sphingolipids
Amino acid
Carbohydrates
Dyeing and dyes
Nucleotides
Vitamins
Analytical Standards
Drug impurity
Derivative analytical reagent
Chromatographic solvent
Analysis materials
Chiral compounds
Amino acid derivatives
Catalysts and Ligands
Benzene ring compounds
Indole compounds
Pyridine compounds
Other heterocyclic compounds
Other synthetic blocks
Inorganic salt
Proteins and Peptides
Analysis and preparation
Chiral analysis and preparation
Customized synthesis
>
K03861
TS3371-5MG
In-stock
240
- +
TS3371-10MG
410
l General Information
Product Name
General description
K03861 is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for CDK2(WT), CDK2(C118L), CDK2(A144C), and CDK2(C118L/A144C), respectlvely.
Synonym
AUZ 454
Purity
≥98.5%(HPLC)
CAS Number
853299-07-7
Formula
C24H26F3N7O2
Molecular Weight
501.5
Suitability
BioReagent, suitable for cell culture, etc.
l Physical and Chemical Information
Appearance
Solid
Solubility(25°C)
DMSO
≥50mg/mL
Ethanol
≥5mg/mL
Water
Very slightly soluble
l Storage
Storage temp.
-20°C
l Precautions and Disclaimer
This product is for R&D use only, not for drug, household, or other uses.
l References
1. http://www.drugbank.ca
2. https://ncit.nci.nih.gov
3. https://www.ncbi.nlm.nih.gov
